We have shown that inhibition of FoxO1 induced phenotypic conversion of hepatocytes and down-regulates lipid synthesis genes expression by hepatocytes, which contribute to lipid deposition in NAFLD. This evidence concerns the gene FOXO1 and metabolic dysfunction-associated steatotic liver disease.